MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00277-023-05474-1

Медицинская библиотека · Annals of hematology · 2023

Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection.

Takenaka Katsuto, Fuji Shigeo, Matsukawa Toshihiro, Uchida Naoyuki, Kobayashi Takeshi, Tanaka Masatsugu, Ara Takahide, Ikegame Kazuhiro, Ozawa Yukiyasu, Kanda Yoshinobu, Sawa Masashi, Maruyama Yumiko, Fukuda Takahiro, Nakamae Hirohisa, Kimura Takafumi, Ogata Masao, Seo Sachiko, Atsuta Yoshiko, Matsuo Keitaro, Nakasone Hideki

СтатьяПеревод в очереди

Аннотация

Cytomegalovirus (CMV) infection is a major infectious complication following allogeneic hematopoietic cell transplantation (allo-HCT). Although letermovir (LMV) prophylaxis dramatically reduces the incidence of early clinically significant CMV (csCMV) infection, it remains unclear whether it has a beneficial effect on nonrelapse mortality (NRM) and overall survival (OS). Herein, we evaluated the impact of LMV prophylaxis on posttransplant outcomes using the registry database of the Japanese Society for Transplantation and Cellular Therapy. Adult patients who underwent allo-HCT between 2017 and 2019 were analyzed (n = 6004). LMV prophylaxis was administered to 1640 patients (LMV group) and it significantly reduced the incidence of csCMV infection compared with those not administered LMV prophylaxis (15.4% vs 54.1%; p < 0.01). However, it did not improve the 1-year NRM (hazard ratio [HR], 0.93; p = 0.40) and OS (HR, 0.96; p = 0.49). In the LMV group, 74 patients had breakthrough csCMV infection and showed inferior NRM (HR, 3.44; p < 0.01) and OS (HR, 1.93; p = 0.02) compared with those without infection. After completing LMV prophylaxis, 252 patients had late csCMV infection and showed inferior NRM (HR, 1.83; p < 0.01) and OS (HR, 1.58; p < 0.01). Our findings suggest that managing breakthrough and late csCMV infections is important for improving long-term outcomes.

Для цитирования: Takenaka Katsuto, Fuji Shigeo, Matsukawa Toshihiro, Uchida Naoyuki, Kobayashi Takeshi, Tanaka Masatsugu, Ara Takahide, Ikegame Kazuhiro, Ozawa Yukiyasu, Kanda Yoshinobu, Sawa Masashi, Maruyama Yumiko, Fukuda Takahiro, Nakamae Hirohisa, Kimura Takafumi, Ogata Masao, Seo Sachiko, Atsuta Yoshiko, Matsuo Keitaro, Nakasone Hideki. Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection.. Annals of hematology. 2023. DOI: 10.1007/s00277-023-05474-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.